Investigation of the Pharmacokinetics of NNC172-2021, at Two Different Dose Levels, in Healthy Japanese Subjects
Status:
Completed
Trial end date:
2012-05-08
Target enrollment:
Participant gender:
Summary
This trial is conducted in Europe. The aim of this trial is to investigate the
pharmacokinetics (how the trial drug is distributed in the body) of NNC172-2021 administered
subcutaneously, at two different dose levels, in healthy Japanese subjects.